This inventor holds 1 USPTO granted patent. Top assignee: Nippon Chemiphar Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Takafumi Muto: Pioneering Research in Peroxisome Proliferator-Activated Receptors
Introduction
Takafumi Muto, an accomplished inventor based in Misato, Japan, has made significant contributions to the field of pharmaceutical innovation. With a keen focus on peroxisome proliferator-activated receptors (PPARs), Muto's work is instrumental in furthering medical science and therapeutic applications.
Latest Patents
Muto holds a notable patent for an activator of peroxisome proliferator-activated receptor alpha. This invention includes a compound defined by a specific chemical formula with various substituents, including hydrogen atoms, halogen atoms, alkyl groups, and more. The diversity in the chemical structure indicates the potential for versatile applications in pharmacology and treatment.
Career Highlights
Muto has established himself in the pharmaceutical sector, currently working with Nippon Chemiphar Co., Ltd. His experience and expertise in the synthesis and application of innovative compounds contribute to the company's mission to advance healthcare through effective medicinal solutions.
Collaborations
Throughout his career, Takafumi Muto has collaborated with esteemed colleagues, including Masuharu Hirano. These partnerships enhance the research environment, enabling the exchange of ideas and fostering innovation in their respective fields.
Conclusion
Takafumi Muto's dedication to innovation and his invaluable contributions to the study of peroxisome proliferator-activated receptors underscore the importance of inventors in advancing medical research. His patent represents a significant step forward in the quest for effective therapies, showcasing the ongoing relevance of science in improving human health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile